Pancreatic Cancer Research

ResearcherVirginia Tech - Wake Forest University School of Biomedical Engineering & SciencesActive in the last 2 years

Scott S. Verbridge

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4074-8799; OpenAlex author ID A5008275970. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
3
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

  1. Electro-antibacterial therapy (EAT) to enhance intracellular bacteria clearance in pancreatic cancer cells. Last author DOI 10.1016/j.bioelechem.2024.108669↗
  2. Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling. Last author DOI 10.1126/scisignal.abn4948↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Josie L. Duncan · 1 shared paper, 2024 · strength 0.26
  2. Rafael V. Davalos · 1 shared paper, 2024 · strength 0.26
  3. Barath Udayasuryan · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.